Patients
377 per 100,000 people
Tuberculosis new cases, DR Congo, 2024 (World Bank).
Compare every country on the Public Health Dashboard
Updated
Reviewed by Chandani Patel
DR Congo TB Molecular Diagnostics Public Health Report: Need and Coverage, Demographic and Geographic Distribution, Risk Factors, Screening and Diagnosis, Treatment Coverage, Programmes, Gaps and Outlook
Only published figures are shown here, with their year and source. The full report keeps reported cases, survey estimates and modelled estimates apart, and names the data gaps.
| Topic | TB Molecular Diagnostics |
|---|---|
| Place | DR Congo |
| Tuberculosis new cases (latest) | 377 per 100,000 people (2024)Source: World Bank Open Data, Tuberculosis new cases (per 100,000 people). Retrieved 18 Nov 2026. |
| Report sections | 16 (table of contents) |
| Formats | PDF, PPTX, XLSX |
Rapid molecular tests find TB and drug resistance within hours, replacing slower sputum microscopy. This report covers cartridge-based tests, line probe assays and near-point-of-care tests.
The report sets out the scale of need for TB molecular diagnostics in DR Congo: who needs it, how many are reached and the health problems it addresses, using TB Incidence, TB Case Notifications, Treatment Success Rate, TB Deaths and Drug-Resistant TB Cases.
Need and coverage are broken down by age (children 0–14 years, adolescents and young adults 15–24 years, adults 25–54 years and adults 55 years and over), gender and income, with a focus on people living with HIV, people with diabetes, undernourished people, household contacts, miners and prisoners and migrants and the urban poor.
Findings are compared across states, provinces and districts where data allows, and between urban, rural and informal settlement areas, to show where needs are greatest and where gaps between places are widest.
Main risk factors include HIV infection, undernutrition, diabetes, smoking and alcohol use, crowded and poorly ventilated housing and silica dust exposure. Income, education, housing, water and sanitation, and gender and social norms are reviewed as social drivers of health.
The report reviews awareness and uptake of TB molecular diagnostics, and how people in need are found, through symptom screening, chest x-ray screening, rapid molecular tests and contact investigation, by group and by area.
It compares the number of people who need TB molecular diagnostics with the number reached, to show the coverage gap and which groups are missed.
Treatment and prevention covered include genexpert MTB/RIF ultra, truenat, sample transport networks and laboratory connectivity, with how widely each is delivered and how well it is sustained.
Health outcomes covered include Post-TB lung disease, drug resistance, catastrophic household costs and TB deaths, and what is known about the effect of TB molecular diagnostics on them.
The report looks at TB clinics and treatment centres, diagnostic laboratories and molecular testing, community health workers and medicine supply chains, the health workforce, and the physical, financial and distance barriers to care, including how people use public and private services.
DR Congo scores 41 out of 100 on the WHO universal health coverage index (2023).[1] People pay 38.0% of all health spending out of their own pockets (2023).[2] Money from abroad pays for 37.0% of health spending (2023).[3] Tuberculosis new cases: 377 per 100,000 people in 2024, the latest World Bank figure for DR Congo.[4]
[1] WHO Global Health Observatory, Universal health coverage index (index (0–100)). Retrieved 18 Nov 2026.
[2] World Bank Open Data, Out-of-pocket spending (% of health spending). Retrieved 18 Nov 2026.
[3] World Bank Open Data, Health spending from abroad (% of health spending). Retrieved 18 Nov 2026.
[4] World Bank Open Data, Tuberculosis new cases (per 100,000 people). Retrieved 18 Nov 2026.
It describes what TB molecular diagnostics costs to deliver, who pays for it and the costs that fall on households, including funding from government, donors and NGOs.
Worldwide guidance and funding for TB molecular diagnostics include WHO End TB Strategy, Stop TB Partnership, The Global Fund to Fight AIDS, Tuberculosis and Malaria and UN High-Level Meeting on TB Commitments. The report reviews national programmes, donor and NGO funding, and what is known about their impact.
Year-wise trends and changes across survey rounds are shown and compared with peer countries, with the data collection year and reporting period stated for each figure.
The report names gaps in screening, diagnosis, treatment and access, the high-risk and underserved communities most affected, and where reliable data is missing.
It looks ahead at future need for TB molecular diagnostics, the resources it will require and the areas most at risk of falling behind.
The report closes with key findings, the population groups to prioritise and recommendations on where to target resources. Figures come from WHO Global Tuberculosis Report, National TB Prevalence Surveys, National TB Programme Notification Data and Global Burden of Disease (IHME). Reported cases, survey estimates and modelled estimates are kept apart, and missing figures are named as data gaps.
What doctors and scientists are doing in TB Molecular Diagnostics Public Health Report right now, from free public sources.
377 per 100,000 people
Tuberculosis new cases, DR Congo, 2024 (World Bank).
Compare every country on the Public Health DashboardSources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 18 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Tuberculosis new cases (per 100,000 people). Retrieved 18 Nov 2026.
[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 18 Nov 2026.
[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 18 Nov 2026.
From our blog
DR Congo · 6 shared keywords
DR Congo · 6 shared keywords
DR Congo · 6 shared keywords
DR Congo · 6 shared keywords
DR Congo · 6 shared keywords
DR Congo · 6 shared keywords
Digital Health · Global
Medical Devices · Global
Medical Devices · Global
Healthcare Services · Global
Medical Devices · Global
Healthcare Services · Global